Celling Biosciences
Steve Melchiode is an experienced entrepreneur and business development professional with a focus on startup companies in the technology and healthcare sectors. Currently, Steve is the President of Celling Biosciences, regenerative medicine, and cell therapy R&D company, where he oversees a team of 75 in all operations, fundraising, sales, international development, and legal and regulatory compliance activities. Steve has been with Celling Biosciences since its inception in 2006 as a medical device company and has been leading the company’s strategic development for more than a decade. Additionally, Steve has been a driving force behind the company’s evolution toward specialization in the regenerative medicine and cell therapy space. In addition to securing over $10 million in the financing, Steve has been a driving force to revenue growth, moving annual revenue to over $20 million and recently leading international development efforts by opening the company’s first overseas office in Brazil, with plans to expand into Europe later this year.
This person is not in the org chart
Celling Biosciences
Celling Biosciences is dedicated to the scientific understanding and therapeutic application of autologous cell therapy.